Skip to content

CARDISIO

The fast and precise screening method for early detection of heart disease and prevention of a surprising heart attack.

Complementing ALiSE, we are launching Cardisio, the perfect product for early detection of heart disease and heart attacks. Most people with coronary artery disease are often symptom-free until they suffer a heart attack or are not diagnosed until they have a heart attack. Cardisio cardiac screening test is the first non-invasive, rapid and accurate screening test for heart disease. The test is based on a three-dimensional measurement of the heart and complies with current and modern standards, its use is fast, inexpensive and effective. The data is transferred anonymously via cloud to a central data processing system. The data analysis is performed immediately by special software and the risk factor of the examined person is determined by means of artificial intelligence and “deep learning” algorithms.

Facebook
Twitter
LinkedIn

Somapharm News

Our Clients